Replies to post #18972 on Mymetics Corp (MYMX)

[bow-tie]

Patrick Scherrer: Member of the board. Chairman of the board and cofounder at G-ray Switzerland SA . Several investments in the technology and life-sciences sectors, including Actelion, Axovan, Endoart, immatics, Sensimed, Symetis, Evolva and Anergis

The newly joining investors also bring substantial pharmaceutical experience and know-how to Anergis: Patrick Scherrer (representing Vinci Capital-Renaissance PME), Markus Hosang (representing BioMedInvest) and Sten Verland (representing Sunstone Capital) have joined the Anergis Board of Directors.
Patrick Scherrer from Vinci Capital-Renaissance PME has joined the Anergis board.

The Board will be chaired by André J. Mueller, a professional with unique executive and non-executive experience in biotech ventures, which he gained with Biogen and Actelion and as the Chairman of the Boards of Cerenis Therapeutics (Toulouse) and Addex Pharmaceuticals (Geneva).
https://www.pressebox.com/inactive/anergis-sa/Anergis-Closes-CHF-18-Million-Series-A-Financing-Round-to-develop-its-Innovative-Allergy-Vaccines-and-Expands-its-Board-of-Directors/boxid/414382
https://anokion.com/people/andre-j-mueller/